StockData

Niki BioSolutions, Inc. (NIKI) stock

NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.68+0.08 (+5.00%)

Close on Nov 19, 2026Market cap $13.68MP/E –Yield –

Niki BioSolutions revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2023 it was $431.38K, down 66.7% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023$431.38K-66.7%
FY2022Dec 31, 2022$1.30M-15.9%
FY2021Dec 31, 2021$1.54M–

More Niki BioSolutions figures

See a number that looks wrong?